GlassScriptPhysician profile
Ancy Varughese Thomas
NPI 1952877409
$5,313.49
in general payments reported to CMS, 2019-2025
58 companies · $2,100 in 2025
The $2,100 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $424 · 2022: $16.27 · 2023: $690 · 2024: $2,083 · 2025: $2,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,853 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,853.02 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $480.34 | 2023-2025 | Tecvayli, Darzalex, Carvykti |
| Astrazeneca Pharmaceuticals LP | $431.88 | 2021-2025 | Imfinzi, Enhertu, Calquence |
| Merck Sharp & Dohme LLC | $408.42 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Daiichi Sankyo INC. | $351.30 | 2024-2025 | Enhertu, Datroway, Vanflyta |
| Pfizer INC. | $250.36 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $222.01 | 2023-2025 | Fruzaqla, Iclusig, Alunbrig |
| Jazz Pharmaceuticals INC. | $200.48 | 2023-2025 | |
| Incyte Corporation | $172.95 | 2024-2025 | Monjuvi, Jakafi |
| Tactile Systems Technology INC | $163.27 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Emd Serono, INC. | $149.87 | 2023-2025 | Bavencio |
| Regeneron Healthcare Solutions, INC. | $141.99 | 2023-2025 | Libtayo, Lynozyfic |
| Eisai INC. | $130.06 | 2024-2025 | |
| Adaptive Biotechnologies Corporation | $127.50 | 2023-2025 | Clonoseq |
| Abbvie INC. | $125.26 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.30 | 2024-2025 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ancy Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.